A Simple In-Vivo Method for Evaluation of Antibiofilm and Wound Healing Activity Using Excision Wound Model in Diabetic Swiss Albino Mice.
MRSA
crystal violet assay
diabetic
modified Gram stain
mupirocin
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
08 Mar 2023
08 Mar 2023
Historique:
received:
09
02
2023
revised:
27
02
2023
accepted:
07
03
2023
medline:
30
3
2023
entrez:
29
3
2023
pubmed:
30
3
2023
Statut:
epublish
Résumé
The study developed a simple and inexpensive method to induce biofilm formation in-vivo for the evaluation of the antibiofilm activity of pharmacological agents using Swiss albino mice. Animals were made diabetic using streptozocin and nicotinamide. A cover slip containing preformed biofilm along with MRSA culture was introduced into the excision wound in these animals. The method was effective in developing biofilm on the coverslip after 24 h incubation in MRSA broth which was confirmed by microscopic examination and a crystal violet assay. Application of preformed biofilm along with microbial culture induced a profound infection with biofilm formation on excision wounds in 72 h. This was confirmed by macroscopic, histological, and bacterial load determination. Mupirocin, a known antibacterial agent effective against MRSA was used to demonstrate antibiofilm activity. Mupirocin was able to completely heal the excised wounds in 19 to 21 days while in the base-treated group, healing took place between 30 and 35 days. The method described is robust and can be reproduced easily without the use of transgenic animals and sophisticated methods such as confocal microscopy.
Identifiants
pubmed: 36985266
pii: microorganisms11030692
doi: 10.3390/microorganisms11030692
pmc: PMC10051147
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Deanship of Scientific Research at Shaqra University
ID : SU-ANN-202238
Références
BMC Res Notes. 2016 Apr 12;9:216
pubmed: 27071769
Adv Sci (Weinh). 2022 Oct;9(29):e2203291
pubmed: 36031384
J Microbiol Methods. 2017 Jul;138:50-59
pubmed: 26979645
Med Microbiol Immunol. 2013 Apr;202(2):131-41
pubmed: 23007678
Expert Rev Anti Infect Ther. 2015 May;13(5):605-13
pubmed: 25746414
Curr Diabetes Rev. 2022;18(8):e171121198001
pubmed: 34789130
Antimicrob Agents Chemother. 2014 Jul;58(7):4113-22
pubmed: 24798285
Biofilm. 2022 Jan 31;4:100069
pubmed: 36569981
Nat Rev Microbiol. 2022 Oct;20(10):608-620
pubmed: 35922483
Virulence. 2021 Dec;12(1):547-569
pubmed: 33522395
J Wound Care. 2022 May 2;31(5):436-445
pubmed: 35579319
Lab Anim. 2011 Jul;45(3):131-40
pubmed: 21478271
World J Gastroenterol. 2018 Jul 28;24(28):3120-3129
pubmed: 30065558
APMIS. 2022 Jul;130(7):458-476
pubmed: 34117660
Exp Biol Med (Maywood). 2012 May;237(5):481-90
pubmed: 22619373
Cold Spring Harb Protoc. 2014 Jun 02;2014(6):655-8
pubmed: 24890205
Virulence. 2011 Jul-Aug;2(4):296-315
pubmed: 21701256
Biomolecules. 2022 Sep 02;12(9):
pubmed: 36139064
J Vis Exp. 2011 Jan 30;(47):
pubmed: 21307833
Adv Wound Care (New Rochelle). 2015 Jul 1;4(7):382-388
pubmed: 26155380
Antibiotics (Basel). 2022 Dec 01;11(12):
pubmed: 36551388
Front Cell Infect Microbiol. 2012 Mar 27;2:39
pubmed: 22919630
ChemMedChem. 2021 Jan 8;16(1):65-80
pubmed: 33090669
Wound Repair Regen. 2010 Sep-Oct;18(5):467-77
pubmed: 20731798
Microorganisms. 2022 Jul 25;10(8):
pubmed: 35893558
Br J Dermatol Syph. 1949 Jun;61(6):206-10
pubmed: 18150076
Front Endocrinol (Lausanne). 2020 Mar 03;11:24
pubmed: 32194500
Front Microbiol. 2021 May 12;12:676458
pubmed: 34054785
J Vis Exp. 2017 Oct 10;(128):
pubmed: 29053700
Cureus. 2022 Mar 16;14(3):e23212
pubmed: 35444898
Microorganisms. 2020 Oct 14;8(10):
pubmed: 33066595
Medchemcomm. 2019 Mar 14;10(8):1231-1241
pubmed: 31534648
Antibiotics (Basel). 2021 Nov 10;10(11):
pubmed: 34827315
J Glob Antimicrob Resist. 2021 Mar;24:169-174
pubmed: 33373736